We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$202M
AUM Growth
-$10.1M
(-4.7%)
Cap. Flow
+$30.2M
Cap. Flow
% of AUM
14.92%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
66
New
5
Increased
31
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$5.4M |
| 2 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$4.95M |
| 3 |
AtriCure
ATRC
|
+$3.16M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$2.95M |
| 5 |
Arrowhead Research
ARWR
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$7.83M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
+$3.38M |
| 3 |
Standard BioTools
LAB
|
+$2.38M |
| 4 |
Verastem
VSTM
|
+$1.72M |
| 5 |
ELGX
Endologix Inc
ELGX
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.82% |
| 2 | Energy | 3.37% |
| 3 | Real Estate | 2.4% |
| 4 | Financials | 0.28% |
| 5 | Consumer Staples | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPHD
26
DELISTED
Cepheid Inc
CPHD
| $2.9M | 1.44% |
64,271
+9,580
| +18% | +$511K |
|
|
STRM
27
DELISTED
Streamline Health Solutions
STRM
| $2.87M | 1.42% |
83,677
+11,182
| +15% | +$451K |
|
|
28
Arrowhead Research
ARWR
$11.9B
| $2.68M | 1.32% |
+465,503
| New | +$2.93M |
|
29
Veracyte
VCYT
$3.7B
| $2.65M | 1.31% |
564,932
+82,669
| +17% | +$787K |
|
30
HealthStream
HSTM
$819M
| $2.58M | 1.28% |
118,352
+17,598
| +17% | +$468K |
|
31
Vertex Pharmaceuticals
VRTX
$121B
| $2.57M | 1.27% |
24,643
+3,545
| +17% | +$455K |
|
32
Celldex Therapeutics
CLDX
$2.99B
| $2.27M | 1.12% |
14,342
+1,986
| +16% | +$562K |
|
|
ELGX
33
DELISTED
Endologix Inc
ELGX
| $2.22M | 1.1% |
18,096
-12,364
| -41% | -$1.68M |
|
34
BioMarin Pharmaceuticals
BMRN
$11.6B
| $2.02M | 1% |
19,153
+2,788
| +17% | +$372K |
|
35
Karyopharm Therapeutics
KPTI
$43.5M
| $1.63M | 0.8% |
+10,314
| New | +$2.76M |
|
|
BLUE
36
DELISTED
bluebird bio
BLUE
| $1.17M | 0.58% |
1,052
+156
| +17% | +$284K |
|
|
ESPR
37
DELISTED
Esperion Therapeutics
ESPR
| $1.13M | 0.56% |
47,965
+28,035
| +141% | +$1.76M |
|
|
PETX
38
DELISTED
Aratana Therapeutics, Inc.
PETX
| $701K | 0.35% |
82,911
+12,291
| +17% | +$208K |
|
39
Humana
HUM
$43.7B
| $634K | 0.31% |
3,540
| – | – |
|
40
Elevance Health
ELV
$81.5B
| $573K | 0.28% |
4,095
| – | – |
|
|
AET
41
DELISTED
Aetna Inc
AET
| $571K | 0.28% |
5,215
| – | – |
|
|
ENDP
42
DELISTED
Endo International plc
ENDP
| $565K | 0.28% |
8,161
| – | – |
|
43
Novartis
NVS
$297B
| $558K | 0.28% |
6,774
| – | – |
|
|
AGN
44
DELISTED
Allergan plc
AGN
| $553K | 0.27% |
2,035
| – | – |
|
45
United Therapeutics
UTHR
$25.8B
| $501K | 0.25% |
3,820
| – | – |
|
46
Bristol-Myers Squibb
BMY
$133B
| $491K | 0.24% |
8,290
| – | – |
|
|
CELG
47
DELISTED
Celgene Corp
CELG
| $463K | 0.23% |
4,280
| – | – |
|
48
Eli Lilly
LLY
$1.02T
| $460K | 0.23% |
5,495
| – | – |
|
49
Becton Dickinson
BDX
$45.6B
| $450K | 0.22% |
3,480
| – | – |
|
50
Steris
STE
$22.3B
| $411K | 0.2% |
6,330
| – | – |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, First Light Asset Management held 66 positions worth $202M, down 4.7% from $212M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
First Light Asset Management deployed $30.2M of net new capital in Q3 2015, opening 5 new positions and adding to 31 existing holdings. Its largest new stake was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier, followed by Energy and Real Estate.
On the sell side, the largest reduction was NxStage Medical Inc., an estimated $3.38M trimmed.
- First Light Asset Management's largest Q3 2015 buy was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.
- First Light Asset Management added most to AtriCure in Q3 2015, an estimated $3.16M increase.
- First Light Asset Management's biggest Q3 2015 reduction was NxStage Medical Inc., cutting an estimated $3.38M.
- First Light Asset Management fully exited AMAG Pharmaceuticals in Q3 2015, selling an estimated $7.83M.
- First Light Asset Management's ten largest holdings make up 49% of its $202M portfolio in Q3 2015.
- First Light Asset Management opened 5 new positions and closed 4 in Q3 2015.
- First Light Asset Management's portfolio value fell 4.7% quarter-over-quarter to $202M.
Based on First Light Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.